CYBERJAYA: DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, has released its financial results for the third quarter (“3QFY25”) and nine months ending 28 February 2025 (“9MFY25”) for the Company and its subsidiaries (“DXN Group” or the “Group”).
3QFY25 Highlights
- Revenue Growth: Increased 8.0% YoY to RM486.1 million (3QFY24: RM450.3 million), driven by stronger sales in Latin America and the Middle East, supported by effective product promotions and member engagement initiatives.
- EBITDA: Rose 17.5% YoY to RM158.0 million (3QFY24: RM134.5 million), with EBITDA margin improving to 32.5% (3QFY24: 29.9%) due to cost optimization and operational efficiency.
- Net Profit: Achieved a record-high net profit of RM92.8 million, up 18.4%, marking the highest quarterly net profit in the Group’s history.
Datuk Lim Siow Jin (拿督林孝仁), Executive Chairman and Founder of DXN, stated:
“DXN continues to experience strong demand across key markets, particularly in Latin America and the Middle East. Our strategic marketing and member engagement efforts have boosted sales momentum, with our extensive member network playing a vital role in expanding market reach. Looking ahead, we aim to strengthen our global footprint, enhance production capabilities, and expand into high-potential markets to solidify our position further.”
9MFY25 Key Metrics
- Revenue: Increased 8.8% YoY to RM1.45 billion (9MFY24: RM1.33 billion), driven by strong sales in Peru, Bolivia, and Turkey.
- EBITDA: Grew 7.6% YoY to RM435.4 million (9MFY24: RM404.5 million).
- Net Profit: Increased 5.3% YoY to RM244.3 million (9MFY24: RM232.0 million).
Dividend Declaration
- DXN’s Board of Directors declared a third interim dividend of 1.0 sen per share for 3QFY25, bringing total dividends for 9MFY25 to 2.7 sen per share.
- Over the past four quarters, total dividends declared amounted to 3.7 sen per share, representing a dividend yield of 7.3%.
Strong Financial Position
- Cash and Cash Equivalents: RM696.2 million as of 30 November 2024, significantly exceeding total borrowings of RM134.2 million.
- Net Operating Cash Flow: RM79.2 million generated in 3QFY25.
With a robust balance sheet and strong cash flow generation, DXN is well-positioned to capitalize on future opportunities, reward shareholders, and strengthen its financial resilience.
Looking Ahead
DXN remains focused on market expansion, product innovation, and operational efficiency, ensuring sustained growth and profitability for FY2025 and beyond.
